Deconvolving Bulk Gene Expression for Cell-Type-Specific Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying cell-type-specific gene expression levels from bulk gene expression data are limited by their ability to reconstruct gene expression for low-abundance cell types and lack confidence estimations, which are crucial for accurate deconvolution in the absence of ground truth data.

Innovation Solution

The method involves high-resolution deconvolution, hierarchical deconvolution, and imputation-based deconvolution, coupled with a confidence ranking system to refine predictions and generate accurate cell-type-specific gene expression levels, using bulk gene expression measurements and cell fractions to identify cell-type-specific gene expression levels and ligand-receptor interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If deconvolution algorithms are used to estimate cell-type-specific expression from bulk gene expression data, then the ability to characterize molecular profiles of different cell types is improved, but the accuracy for low-abundance cell types deteriorates

Engineering Contradiction:
Improvecell-type-specific expression estimationVSAvoidlow-abundance cell type accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent segments the bulk gene expression data into distinct cell-type-specific components through iterative deconvolution. The method divides the complex mixture into individual cell type contributions by using reference expression profiles and solving the inverse problem, thereby improving the reliability of low-abundance cell type estimation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a confidence score dimension to evaluate deconvolution results. By adding this quality metric dimension, the method can distinguish reliable estimates from unreliable ones, particularly for low-abundance cell types, thus improving overall reliability without sacrificing measurement precision.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Loss of information

If deconvolution methods are applied to extract cell-type-specific expression from bulk data, then the knowledge of tumor microenvironment is advanced, but the confidence estimation of predictions is lacking

Engineering Contradiction:
Improvecell-type-specific expression recoveryVSAvoidprediction confidence
Core Design Contradiction:
Loss of informationVSReliability

Solution Approach 1:

The patent implements a feedback mechanism where confidence scores are calculated for each deconvolution prediction based on the consistency between observed bulk expression and reconstructed cell-type-specific expression. This feedback loop allows the method to identify and flag low-confidence predictions, particularly for genes in low-abundance cell types, thereby providing reliable confidence estimation.

Inventive Principle:
Principle #23Feedback

3Quantity of substance

If multiple deconvolution approaches are used to improve gene expression reconstruction, then the coverage of reconstructable genes is increased, but the complexity of the method increases

Engineering Contradiction:
Improvenumber of reconstructable genesVSAvoiddeconvolution method complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent merges multiple deconvolution approaches into a unified framework that iteratively refines estimates. By combining different computational strategies and integrating them into a single coherent algorithm, the method increases the number of reconstructable genes while managing complexity through systematic integration rather than separate independent analyses.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS20230049525A1Methods of identifying cell-type-specific gene expression levels by deconvolving bulk gene expression
Publication Date: 2023.02.16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US20230049525A1 patent drawing
  • US20230049525A1 patent drawing
  • US20230049525A1 patent drawing

AI summary

Provided herein are methods of identifying gene expression levels in specific cell types based on bulk gene expression levels measured in tissue samples comprising a plurality of cell types.